An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients

The global elderly population is on the rise, and infections tend to have a higher mortality rate among older individuals. Aging is associated with the progressive impairment of multi-organ function, which can impact the pharmacokinetics of antimicrobials, potentially leading to the failure of anti-...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2024-09, Vol.15, p.1396994
Main Authors: Fu, Guanshuang, Sun, Weijia, Tan, Zhaoyi, Liang, Beibei, Cai, Yun
Format: Article
Language:English
Subjects:
anti-infective therapy
antimicrobial agents
drug resistance
elderly
pharmacokinetics
Pharmacology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c350t-e90e06d20c27a409ea19aa5c030875a6e7bf5922ee8f3dc4740123cd3b35b6ca3
container_end_page
container_issue
container_start_page 1396994
container_title Frontiers in pharmacology
container_volume 15
creator Fu, Guanshuang
Sun, Weijia
Tan, Zhaoyi
Liang, Beibei
Cai, Yun
description The global elderly population is on the rise, and infections tend to have a higher mortality rate among older individuals. Aging is associated with the progressive impairment of multi-organ function, which can impact the pharmacokinetics of antimicrobials, potentially leading to the failure of anti-infective therapy. With the increasing life expectancy, a significant growth in the elderly demographic, and the escalating costs of healthcare, gaining a thorough understanding of pharmacokinetic changes in the elderly holds crucial clinical significance. This review compiles findings from published studies, offering a comprehensive overview of the pharmacokinetics of various antimicrobials in both adults and the elderly. Furthermore, it delves into advancements in pharmacokinetic methods specific to the elderly population.
doi_str_mv 10.3389/fphar.2024.1396994
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_401c1f207722413091225b5526baaf68</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_401c1f207722413091225b5526baaf68</doaj_id><sourcerecordid>3116676576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c350t-e90e06d20c27a409ea19aa5c030875a6e7bf5922ee8f3dc4740123cd3b35b6ca3</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhiMEolXpH-CAcuSyi-3xR3xCVcVHpUpc4GxNnMmuSxIHO4vU_nqc7lK1vow9885jj9-qes_ZFqCxn_p5j2krmJBbDlZbK19V51xr2NiGi9fP9mfVZc53rCywFrR8W52BlQxK23nlr6Y6TDns9kuJS6xX7Ig-_g4TLcHnGqeu7mKmOs5LGMMDLiFOdexLYT37FNuAQ9HtaFpygdQ0dJSG-3ou0jX3rnrTFwVdnuJF9evrl5_X3ze3P77dXF_dbjwotmzIMmK6E8wLg5JZQm4RlWfAGqNQk2l7ZYUganrovDSScQG-gxZUqz3CRXVz5HYR79ycwojp3kUM7jER085hKjMN5Eqr571gxgghOTDLhVCtUkK3iL1uCuvzkTUf2pE6X-ZIOLyAvqxMYe928a_jXBquG1EIH0-EFP8cKC9uDNnTMOBE8ZAd8OKQ0croIhVHafnMnBP1T_dw5la33aPbbnXbndwuTR-ev_Cp5b-38A9szKhB</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3116676576</pqid></control><display><type>article</type><title>An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients</title><source>Open Access: PubMed Central</source><creator>Fu, Guanshuang ; Sun, Weijia ; Tan, Zhaoyi ; Liang, Beibei ; Cai, Yun</creator><creatorcontrib>Fu, Guanshuang ; Sun, Weijia ; Tan, Zhaoyi ; Liang, Beibei ; Cai, Yun</creatorcontrib><description>The global elderly population is on the rise, and infections tend to have a higher mortality rate among older individuals. Aging is associated with the progressive impairment of multi-organ function, which can impact the pharmacokinetics of antimicrobials, potentially leading to the failure of anti-infective therapy. With the increasing life expectancy, a significant growth in the elderly demographic, and the escalating costs of healthcare, gaining a thorough understanding of pharmacokinetic changes in the elderly holds crucial clinical significance. This review compiles findings from published studies, offering a comprehensive overview of the pharmacokinetics of various antimicrobials in both adults and the elderly. Furthermore, it delves into advancements in pharmacokinetic methods specific to the elderly population.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2024.1396994</identifier><identifier>PMID: 39403139</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>anti-infective therapy ; antimicrobial agents ; drug resistance ; elderly ; pharmacokinetics ; Pharmacology</subject><ispartof>Frontiers in pharmacology, 2024-09, Vol.15, p.1396994</ispartof><rights>Copyright © 2024 Fu, Sun, Tan, Liang and Cai.</rights><rights>Copyright © 2024 Fu, Sun, Tan, Liang and Cai. 2024 Fu, Sun, Tan, Liang and Cai</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c350t-e90e06d20c27a409ea19aa5c030875a6e7bf5922ee8f3dc4740123cd3b35b6ca3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11471682/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11471682/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39403139$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fu, Guanshuang</creatorcontrib><creatorcontrib>Sun, Weijia</creatorcontrib><creatorcontrib>Tan, Zhaoyi</creatorcontrib><creatorcontrib>Liang, Beibei</creatorcontrib><creatorcontrib>Cai, Yun</creatorcontrib><title>An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients</title><title>Frontiers in pharmacology</title><addtitle>Front Pharmacol</addtitle><description>The global elderly population is on the rise, and infections tend to have a higher mortality rate among older individuals. Aging is associated with the progressive impairment of multi-organ function, which can impact the pharmacokinetics of antimicrobials, potentially leading to the failure of anti-infective therapy. With the increasing life expectancy, a significant growth in the elderly demographic, and the escalating costs of healthcare, gaining a thorough understanding of pharmacokinetic changes in the elderly holds crucial clinical significance. This review compiles findings from published studies, offering a comprehensive overview of the pharmacokinetics of various antimicrobials in both adults and the elderly. Furthermore, it delves into advancements in pharmacokinetic methods specific to the elderly population.</description><subject>anti-infective therapy</subject><subject>antimicrobial agents</subject><subject>drug resistance</subject><subject>elderly</subject><subject>pharmacokinetics</subject><subject>Pharmacology</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1v1DAQhiMEolXpH-CAcuSyi-3xR3xCVcVHpUpc4GxNnMmuSxIHO4vU_nqc7lK1vow9885jj9-qes_ZFqCxn_p5j2krmJBbDlZbK19V51xr2NiGi9fP9mfVZc53rCywFrR8W52BlQxK23nlr6Y6TDns9kuJS6xX7Ig-_g4TLcHnGqeu7mKmOs5LGMMDLiFOdexLYT37FNuAQ9HtaFpygdQ0dJSG-3ou0jX3rnrTFwVdnuJF9evrl5_X3ze3P77dXF_dbjwotmzIMmK6E8wLg5JZQm4RlWfAGqNQk2l7ZYUganrovDSScQG-gxZUqz3CRXVz5HYR79ycwojp3kUM7jER085hKjMN5Eqr571gxgghOTDLhVCtUkK3iL1uCuvzkTUf2pE6X-ZIOLyAvqxMYe928a_jXBquG1EIH0-EFP8cKC9uDNnTMOBE8ZAd8OKQ0croIhVHafnMnBP1T_dw5la33aPbbnXbndwuTR-ev_Cp5b-38A9szKhB</recordid><startdate>20240930</startdate><enddate>20240930</enddate><creator>Fu, Guanshuang</creator><creator>Sun, Weijia</creator><creator>Tan, Zhaoyi</creator><creator>Liang, Beibei</creator><creator>Cai, Yun</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240930</creationdate><title>An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients</title><author>Fu, Guanshuang ; Sun, Weijia ; Tan, Zhaoyi ; Liang, Beibei ; Cai, Yun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c350t-e90e06d20c27a409ea19aa5c030875a6e7bf5922ee8f3dc4740123cd3b35b6ca3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>anti-infective therapy</topic><topic>antimicrobial agents</topic><topic>drug resistance</topic><topic>elderly</topic><topic>pharmacokinetics</topic><topic>Pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fu, Guanshuang</creatorcontrib><creatorcontrib>Sun, Weijia</creatorcontrib><creatorcontrib>Tan, Zhaoyi</creatorcontrib><creatorcontrib>Liang, Beibei</creatorcontrib><creatorcontrib>Cai, Yun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fu, Guanshuang</au><au>Sun, Weijia</au><au>Tan, Zhaoyi</au><au>Liang, Beibei</au><au>Cai, Yun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients</atitle><jtitle>Frontiers in pharmacology</jtitle><addtitle>Front Pharmacol</addtitle><date>2024-09-30</date><risdate>2024</risdate><volume>15</volume><spage>1396994</spage><pages>1396994-</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>The global elderly population is on the rise, and infections tend to have a higher mortality rate among older individuals. Aging is associated with the progressive impairment of multi-organ function, which can impact the pharmacokinetics of antimicrobials, potentially leading to the failure of anti-infective therapy. With the increasing life expectancy, a significant growth in the elderly demographic, and the escalating costs of healthcare, gaining a thorough understanding of pharmacokinetic changes in the elderly holds crucial clinical significance. This review compiles findings from published studies, offering a comprehensive overview of the pharmacokinetics of various antimicrobials in both adults and the elderly. Furthermore, it delves into advancements in pharmacokinetic methods specific to the elderly population.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>39403139</pmid><doi>10.3389/fphar.2024.1396994</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2024-09, Vol.15, p.1396994
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_401c1f207722413091225b5526baaf68
source Open Access: PubMed Central
subjects anti-infective therapy
antimicrobial agents
drug resistance
elderly
pharmacokinetics
Pharmacology
title An insight into pharmacokinetics and dose optimization of antimicrobials agents in elderly patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T08%3A40%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20insight%20into%20pharmacokinetics%20and%20dose%20optimization%20of%20antimicrobials%20agents%20in%20elderly%20patients&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Fu,%20Guanshuang&rft.date=2024-09-30&rft.volume=15&rft.spage=1396994&rft.pages=1396994-&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2024.1396994&rft_dat=%3Cproquest_doaj_%3E3116676576%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c350t-e90e06d20c27a409ea19aa5c030875a6e7bf5922ee8f3dc4740123cd3b35b6ca3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3116676576&rft_id=info:pmid/39403139&rfr_iscdi=true